{"id":"amantadine-sulfate","safety":{"commonSideEffects":[{"rate":"5-10%","effect":"Nervousness or anxiety"},{"rate":"5-10%","effect":"Insomnia"},{"rate":"5-10%","effect":"Dizziness"},{"rate":"1-5%","effect":"Livedo reticularis"},{"rate":"1-5%","effect":"Orthostatic hypotension"},{"rate":"5-10%","effect":"Nausea"}]},"_chembl":{"chemblId":"CHEMBL465617","moleculeType":"Small molecule","molecularWeight":"249.33"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"As an antiviral, amantadine inhibits the M2 proton channel required for viral uncoating within host cells, thereby blocking influenza A virus replication. Additionally, amantadine has dopaminergic activity through unclear mechanisms, making it useful in treating Parkinson's disease and other movement disorders by enhancing dopamine availability in the brain.","oneSentence":"Amantadine blocks the M2 ion channel of influenza A virus, preventing viral uncoating and replication, and also increases dopamine release in the central nervous system.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T00:21:17.354Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Influenza A prophylaxis and treatment"},{"name":"Parkinson's disease"},{"name":"Drug-induced extrapyramidal reactions"}]},"trialDetails":[{"nctId":"NCT04367883","phase":"","title":"Influenza Vaccination, ACEI and ARB in the Evolution of SARS-CoV2 Infection","status":"RECRUITING","sponsor":"Consorci Sanitari de Terrassa","startDate":"2020-03-01","conditions":"COVID19, Influenza Vaccination, ACE Inhibitors","enrollment":3000},{"nctId":"NCT05504057","phase":"","title":"Antihistamines, Amantadine and Evolution of the SARS-CoV-2 Infection","status":"RECRUITING","sponsor":"Consorci Sanitari de Terrassa","startDate":"2020-03-01","conditions":"COVID-19","enrollment":140660},{"nctId":"NCT07470606","phase":"PHASE2","title":"Memantine +/- Raloxifene for Cognitive Preservation After Radiation Therapy to the Brain","status":"NOT_YET_RECRUITING","sponsor":"The University of Texas Health Science Center at San Antonio","startDate":"2026-03","conditions":"Brain Tumor","enrollment":108},{"nctId":"NCT07151378","phase":"PHASE3","title":"Intestinal Levodopa + Entacapone Therapy (Lecigon®) to Counteract Dopaminergic Desensitization and Neuropsychiatric Complications in Parkinson's Disease","status":"RECRUITING","sponsor":"University Hospital Tuebingen","startDate":"2025-10-27","conditions":"PARKINSON DISEASE (Disorder)","enrollment":150},{"nctId":"NCT04302870","phase":"PHASE2, PHASE3","title":"Motor Neurone Disease - Systematic Multi-Arm Adaptive Randomised Trial","status":"RECRUITING","sponsor":"University of Edinburgh","startDate":"2020-02-27","conditions":"Motor Neuron Disease, Amyotrophic Lateral Sclerosis","enrollment":1150},{"nctId":"NCT04966546","phase":"EARLY_PHASE1","title":"Targeting Spreading Depolarization After Chronic Subdural Hematoma Surgery (TASD)","status":"WITHDRAWN","sponsor":"University of New Mexico","startDate":"2022-06-01","conditions":"Chronic Subdural Hematoma","enrollment":""},{"nctId":"NCT03553875","phase":"PHASE3","title":"Memantine for the Treatment of Social Deficits in Youth With Disorders of Impaired Social Interactions","status":"TERMINATED","sponsor":"Massachusetts General Hospital","startDate":"2018-11-13","conditions":"Autism, Autism Spectrum Disorder, Nonverbal Learning Disability","enrollment":25},{"nctId":"NCT07421427","phase":"NA","title":"Adding Amantadine or Duloxetine to Pregabalin on Occurrence of Post Mastectomy Pain Syndrome","status":"RECRUITING","sponsor":"Cairo University","startDate":"2026-02-21","conditions":"Amantadine, Duloxetine, Pregabalin","enrollment":150},{"nctId":"NCT07248228","phase":"PHASE2","title":"Memory Avoidance Whole Brain Radiotherapy vs Hippocampal Avoidance Whole Brain Radiotherapy (Athena 2 Trial)","status":"NOT_YET_RECRUITING","sponsor":"Case Comprehensive Cancer Center","startDate":"2026-03","conditions":"Brain Metastases","enrollment":90},{"nctId":"NCT07417670","phase":"PHASE4","title":"Satisfaction With Orodispersible vs Conventional Memantine in Moderate to Severe Alzheimer's Disease","status":"COMPLETED","sponsor":"Carnot Laboratories","startDate":"2024-10-04","conditions":"Alzheimer Disease","enrollment":105},{"nctId":"NCT03527472","phase":"PHASE2","title":"Memantine for the Treatment of Cognitive Impairment in Systemic Lupus Erythematosus","status":"ACTIVE_NOT_RECRUITING","sponsor":"Vanderbilt University Medical Center","startDate":"2018-08-23","conditions":"Lupus Erythematosus, Systemic","enrollment":111},{"nctId":"NCT04857983","phase":"PHASE2, PHASE3","title":"Memantine Augmentation of Targeted Cognitive Training in Schizophrenia","status":"COMPLETED","sponsor":"University of California, San Diego","startDate":"2021-07-06","conditions":"Schizophrenia, Schizoaffective Disorder","enrollment":62},{"nctId":"NCT06055244","phase":"PHASE2","title":"Amantadine Therapy for Cognitive Impairment in Long COVID","status":"COMPLETED","sponsor":"Ohio State University","startDate":"2023-12-07","conditions":"Long COVID, Post-COVID19 Condition, Post-Acute COVID19 Syndrome","enrollment":64},{"nctId":"NCT07351773","phase":"NA","title":"Ultrasound-Guided Stellate Ganglion Block for Alzheimer's Disease","status":"COMPLETED","sponsor":"Taizhou Second People's Hospital","startDate":"2025-01-26","conditions":"Alzheimer's Disease(AD), Cognitive Dysfunction","enrollment":40},{"nctId":"NCT05063851","phase":"PHASE2","title":"The Use of Memantine for Prevention of Alzheimer's Disease","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Virginia","startDate":"2021-10-11","conditions":"Alzheimer Disease","enrollment":32},{"nctId":"NCT04804644","phase":"PHASE3","title":"Testing if High Dose Radiation Only to the Sites of Brain Cancer Compared to Whole Brain Radiation That Avoids the Hippocampus is Better at Preventing Loss of Memory and Thinking Ability","status":"RECRUITING","sponsor":"NRG Oncology","startDate":"2021-06-10","conditions":"Metastatic Lung Small Cell Carcinoma, Metastatic Malignant Neoplasm in the Brain, Recurrent Lung Small Cell Carcinoma","enrollment":200},{"nctId":"NCT03550391","phase":"PHASE3","title":"Stereotactic Radiosurgery Compared With Hippocampal-Avoidant Whole Brain Radiotherapy (HA-WBRT) Plus Memantine for 5 or More Brain Metastases","status":"RECRUITING","sponsor":"Canadian Cancer Trials Group","startDate":"2018-11-22","conditions":"Brain Metastases","enrollment":206},{"nctId":"NCT03703856","phase":"PHASE4","title":"Biomarker Predictors of Memantine Sensitivity in Patients With Alzheimer's Disease","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of California, San Diego","startDate":"2019-01-31","conditions":"Alzheimer Disease","enrollment":53},{"nctId":"NCT06833203","phase":"NA","title":"Adding Amantadine to Pregabalin on Occurrence of Post-thoracotomy Pain Syndrome","status":"COMPLETED","sponsor":"Cairo University","startDate":"2023-12-01","conditions":"Amantadine, Pregabalin, Post-thoracotomy Pain Syndrome","enrollment":60},{"nctId":"NCT05418049","phase":"PHASE2","title":"Evaluating the Neurophysiologic and Clinical Effects of Single Dose Drug Challenge","status":"ACTIVE_NOT_RECRUITING","sponsor":"Children's Hospital Medical Center, Cincinnati","startDate":"2022-09-08","conditions":"Fragile X Syndrome","enrollment":45},{"nctId":"NCT04939597","phase":"PHASE3","title":"A Study to See if Memantine Protects the Brain During Radiation Therapy Treatment for a Brain Tumor","status":"ACTIVE_NOT_RECRUITING","sponsor":"Children's Oncology Group","startDate":"2022-05-10","conditions":"Central Nervous System Carcinoma","enrollment":192},{"nctId":"NCT02144584","phase":"EARLY_PHASE1","title":"Memantine for Enhanced Stroke Recovery","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Utah","startDate":"2014-01","conditions":"Ischemic Stroke, Upper Extremity Weakness","enrollment":20},{"nctId":"NCT07251023","phase":"PHASE3","title":"Efficacy and Safety of DMB-I (INN: Latrepirdine) in Patients With Alzheimer Type Dementia","status":"RECRUITING","sponsor":"Bigespas LTD","startDate":"2025-11-20","conditions":"Alzheimer Type Dementia","enrollment":450},{"nctId":"NCT05013892","phase":"PHASE2","title":"NTS-WBRT in Brain Metastases","status":"RECRUITING","sponsor":"Massachusetts General Hospital","startDate":"2022-02-08","conditions":"Brain Metastases","enrollment":41},{"nctId":"NCT05796752","phase":"PHASE2, PHASE3","title":"Behavioral Treatment and Memantine in Body Focused Repetitive Behaviors","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Chicago","startDate":"2023-08-02","conditions":"Skin-Picking, Trichotillomania (Hair-Pulling Disorder)","enrollment":26},{"nctId":"NCT06501638","phase":"PHASE2","title":"Efficacy and Safety of memanTine in the Treatment Of Frequently symPtomatic Atrial Premature Beats","status":"COMPLETED","sponsor":"Shanghai East Hospital","startDate":"2024-08-29","conditions":"Atrial Premature Beats, Contractions, or Systoles","enrollment":256},{"nctId":"NCT06052787","phase":"PHASE3","title":"Combined Cerebrolysin and Amantadine Sulfate Administration for Patients With Traumatic Brain Injury in the ICU","status":"COMPLETED","sponsor":"Ain Shams University","startDate":"2023-09-01","conditions":"Traumatic Brain Injury","enrollment":150},{"nctId":"NCT07164794","phase":"PHASE2","title":"Memantine Hydrochloride in Prostate Cancer Patients","status":"NOT_YET_RECRUITING","sponsor":"Bin Xu","startDate":"2025-11","conditions":"Metastatic Castration-resistant Prostate Cancer (mCRPC), Prostate Cancer, Neuroendocrine Prostate Cancer (NEPC)","enrollment":15},{"nctId":"NCT00262470","phase":"PHASE1, PHASE2","title":"Treatment of Orthostatic Intolerance","status":"ACTIVE_NOT_RECRUITING","sponsor":"Satish R. Raj","startDate":"1997-04","conditions":"Tachycardia, Chronic Orthostatic Intolerance","enrollment":150},{"nctId":"NCT06789757","phase":"PHASE2","title":"The Study of Atezolizumab, Bevacizumab and Memantine in Patients With Hepatocellular Carcinoma (HCC)","status":"RECRUITING","sponsor":"Inova Health Care Services","startDate":"2025-02-25","conditions":"Hepatocellular Carcinoma","enrollment":19},{"nctId":"NCT06007846","phase":"PHASE2, PHASE3","title":"A Prospective Study of Memantine in Patients With Cirrhosis and Liver Cancer","status":"RECRUITING","sponsor":"Inova Health Care Services","startDate":"2023-07-31","conditions":"Hepatocellular Carcinoma, Cirrhosis","enrollment":12},{"nctId":"NCT06041789","phase":"PHASE2","title":"Effect of Acetylcholinesterase Inhibitors on Bone Metabolism","status":"RECRUITING","sponsor":"Duke University","startDate":"2025-02-03","conditions":"Osteoporosis","enrollment":45},{"nctId":"NCT02466191","phase":"PHASE4","title":"Treatment of Pendular Nystagmus in OPT","status":"COMPLETED","sponsor":"Hospices Civils de Lyon","startDate":"2015-06","conditions":"Pendular Nystagmus, Oculopalatal Tremor","enrollment":7},{"nctId":"NCT01744444","phase":"PHASE2","title":"Treatment of Pendular Nystagmus With Gabapentin and Memantine in Patients With Multiple Sclerosis","status":"COMPLETED","sponsor":"Hospices Civils de Lyon","startDate":"2012-11","conditions":"Pendular Nystagmus Patients With Multiple Sclerosis","enrollment":10},{"nctId":"NCT06727773","phase":"PHASE2","title":"Memantine and Exercise to Improve Cognitive Function and Modulate Biological Pathways of Cognitive Decline During Chemotherapy in Breast Cancer","status":"RECRUITING","sponsor":"UNC Lineberger Comprehensive Cancer Center","startDate":"2025-05-07","conditions":"Breast Cancer, Locally Advanced Breast Cancer, Cognitive Impairment","enrollment":90},{"nctId":"NCT06234462","phase":"PHASE2","title":"A Study of Amantadine for Cognitive Dysfunction in Patients With Long-Covid","status":"WITHDRAWN","sponsor":"University of Texas Southwestern Medical Center","startDate":"2025-06","conditions":"Long COVID, Post-Acute COVID-19 Syndrome","enrollment":""},{"nctId":"NCT07125222","phase":"PHASE2","title":"Use of Gocovri to Improve Disability Due to Radiation Encephalopathy","status":"NOT_YET_RECRUITING","sponsor":"Weill Medical College of Cornell University","startDate":"2025-09","conditions":"Radiation Encephalopathy","enrollment":24},{"nctId":"NCT07113015","phase":"NA","title":"A Study Comparing Propranolol and Amantadine for Reducing Tremors in People With Parkinson's Disease","status":"COMPLETED","sponsor":"Multan Medical And Dental College","startDate":"2024-07-05","conditions":"Parkinson Disease (PD), Tremor","enrollment":220},{"nctId":"NCT00199719","phase":"PHASE2","title":"Study of the Pharmacokinetic Action of Amantadine and Ribavirin in Chronic Hepatitis C. CINAM","status":"COMPLETED","sponsor":"University Hospital, Limoges","startDate":"2003-06","conditions":"Chronic Hepatitis C","enrollment":30},{"nctId":"NCT06253923","phase":"PHASE2","title":"Study to Assess the Safety of Amantadine Hydrochloride (HCl) Intravenous (IV) Solution (MR-301) in Patients With Severe Traumatic Brain Injury (TBI).","status":"ACTIVE_NOT_RECRUITING","sponsor":"SHINKEI Therapeutics, Inc","startDate":"2024-06-01","conditions":"Traumatic Brain Injury","enrollment":45},{"nctId":"NCT02994719","phase":"","title":"Gait Analysis in Neurological Disease","status":"RECRUITING","sponsor":"Beth Israel Deaconess Medical Center","startDate":"2016-03-01","conditions":"Parkinson's Disease, Parkinsonian Disorders, Atypical Parkinson Disease","enrollment":120},{"nctId":"NCT04588246","phase":"PHASE3","title":"Comparing Whole Brain Radiotherapy Using a Technique That Avoids the Hippocampus to Stereotactic Radiosurgery in Patients With Cancer That Has Spread to the Brain and Come Back in Other Areas of the Brain After Earlier Stereotactic Radiosurgery","status":"TERMINATED","sponsor":"NRG Oncology","startDate":"2021-08-05","conditions":"Anatomic Stage IV Breast Cancer AJCC v8, Metastatic Lung Non-Small Cell Carcinoma, Metastatic Lung Small Cell Carcinoma","enrollment":19},{"nctId":"NCT04539951","phase":"PHASE2","title":"Pragmatic Trial of Obsessive-compulsive Disorder","status":"RECRUITING","sponsor":"Shanghai Mental Health Center","startDate":"2020-09-22","conditions":"Obsessive-Compulsive Disorder","enrollment":1600},{"nctId":"NCT01430351","phase":"PHASE1","title":"Temozolomide, Memantine Hydrochloride, Mefloquine, and Metformin Hydrochloride in Treating Patients With Glioblastoma Multiforme After Radiation Therapy","status":"TERMINATED","sponsor":"M.D. Anderson Cancer Center","startDate":"2011-09-14","conditions":"Glioblastoma, Gliosarcoma, Supratentorial Glioblastoma","enrollment":144},{"nctId":"NCT05045950","phase":"PHASE2","title":"Optimizing Neurocognition With Whole Brain Radiation Therapy (WBRT) Using Upfront Pulsed Reduced Dose-Rate (PRDR) Technique","status":"RECRUITING","sponsor":"Medical College of Wisconsin","startDate":"2021-11-17","conditions":"Brain Metastases","enrollment":53},{"nctId":"NCT02360215","phase":"PHASE3","title":"Memantine Hydrochloride and Whole-Brain Radiotherapy With or Without Hippocampal Avoidance in Reducing Neurocognitive Decline in Patients With Brain Metastases","status":"COMPLETED","sponsor":"NRG Oncology","startDate":"2015-07","conditions":"Cognitive Impairment, Metastatic Malignant Neoplasm in the Brain, Solid Neoplasm","enrollment":518},{"nctId":"NCT06275035","phase":"PHASE3","title":"Evaluation of Memantine in the Preservation of Memory and Neurocognition Following CSI","status":"RECRUITING","sponsor":"Tata Memorial Centre","startDate":"2024-02-22","conditions":"Neurocognitive Dysfunction","enrollment":101},{"nctId":"NCT06914310","phase":"PHASE2, PHASE3","title":"Memantine as an Additive Therapy in Patients With Traumatic Brain Injury","status":"NOT_YET_RECRUITING","sponsor":"Mansoura University","startDate":"2025-03-25","conditions":"Mild Traumatic Brain Injury, Moderate Traumatic Brain Injury (TBI)","enrollment":80},{"nctId":"NCT05140148","phase":"PHASE2","title":"Promoting Recovery After STroke With Amantadine","status":"RECRUITING","sponsor":"University of Pennsylvania","startDate":"2022-02-01","conditions":"Stroke, Ischemic, Stroke Hemorrhagic","enrollment":60},{"nctId":"NCT06817200","phase":"PHASE2","title":"The Effect of Amantadine as add-on Therapy for Motor Fluctuations in Advanced Parkinson's Disease: a Randomized Double-blinded Placebo-controlled Trial","status":"NOT_YET_RECRUITING","sponsor":"University Hospital, Toulouse","startDate":"2025-05-01","conditions":"Parkinson Disease (PD)","enrollment":132},{"nctId":"NCT04117178","phase":"PHASE4","title":"Monitoring Anti-Dementia Drugs by Serum Levels","status":"COMPLETED","sponsor":"Zealand University Hospital","startDate":"2020-02-04","conditions":"Dementia, Dementia With Lewy Bodies, Dementia in Parkinsons Disease","enrollment":132},{"nctId":"NCT04789915","phase":"PHASE1","title":"Add-on MEmaNtine to Dopamine Modulation to Improve Negative Symptoms at First Psychosis","status":"RECRUITING","sponsor":"Bjorn H. Ebdrup","startDate":"2021-05-26","conditions":"Psychosis, Negative Symptoms With Primary Psychotic Disorder","enrollment":46},{"nctId":"NCT04217694","phase":"EARLY_PHASE1","title":"Memantine for the Reduction of Cognitive Impairment After Radiation Therapy in Pediatric Patients With Central Nervous System Tumors","status":"COMPLETED","sponsor":"Mayo Clinic","startDate":"2020-02-17","conditions":"Malignant Central Nervous System Neoplasm, Primary Central Nervous System Neoplasm","enrollment":18},{"nctId":"NCT06679387","phase":"PHASE2","title":"\"The Effect of Memantine on the Prevention and Amelioration of Paclitaxel-induced Toxicity in Breast Cancer Patients\"","status":"RECRUITING","sponsor":"Ain Shams University","startDate":"2024-10-30","conditions":"Breast Cancer Early Stage Breast Cancer (Stage 1-3)","enrollment":80},{"nctId":"NCT04387773","phase":"PHASE4","title":"Effect of GOCOVRI (Amantadine, Extended Release Capsules) on Gait in Parkinson's Disease","status":"COMPLETED","sponsor":"Oregon Health and Science University","startDate":"2020-11-05","conditions":"Parkinson Disease","enrollment":8},{"nctId":"NCT06594172","phase":"PHASE2","title":"Early Application of Memantine and Pioglitazone to Protect Cognitive Function After Radiotherapy","status":"NOT_YET_RECRUITING","sponsor":"Affiliated Cancer Hospital & Institute of Guangzhou Medical University","startDate":"2024-09-10","conditions":"Radiation Disease, Cognitive Impairment, Drug Effect","enrollment":67},{"nctId":"NCT04792645","phase":"PHASE2","title":"Memantine in Body Focused Repetitive Behaviors","status":"COMPLETED","sponsor":"University of Chicago","startDate":"2021-06-15","conditions":"Trichotillomania (Hair-Pulling Disorder), Dermatillomania","enrollment":100},{"nctId":"NCT06337994","phase":"PHASE3","title":"Memantine Hydrochloride for Treatment of Cognitive Dysfunction Due to Traumatic Brain Injury","status":"COMPLETED","sponsor":"Assiut University","startDate":"2024-01-01","conditions":"Treatment of Cognitive Deficits After Traumatic Brain Injury","enrollment":60},{"nctId":"NCT01333865","phase":"PHASE4","title":"A Study of Memantine Hydrochloride (Namenda®) for Cognitive and Behavioral Impairment in Adults With Autism Spectrum Disorders","status":"COMPLETED","sponsor":"Massachusetts General Hospital","startDate":"2010-01","conditions":"Autism Spectrum Disorders","enrollment":25},{"nctId":"NCT01972074","phase":"PHASE3","title":"Behavioral and Neural Response to Memantine in Adolescents With Autism Spectrum Disorder","status":"COMPLETED","sponsor":"Massachusetts General Hospital","startDate":"2015-02-17","conditions":"Autism Spectrum Disorder","enrollment":84},{"nctId":"NCT06443827","phase":"PHASE2","title":"Effect of Intravenous Amantadine Sulphate on Disorders of Consciousness","status":"ACTIVE_NOT_RECRUITING","sponsor":"Azienda Sanitaria dell'Alto Adige","startDate":"2018-09-15","conditions":"Amantadine, Consciousness Disorders, Electroencephalography","enrollment":18},{"nctId":"NCT03430817","phase":"PHASE4","title":"Citicholine-Amantadine Trial in Traumatic Brain Injury","status":"COMPLETED","sponsor":"Ain Shams University","startDate":"2017-12-07","conditions":"Intensive Care Unit","enrollment":45},{"nctId":"NCT05664464","phase":"PHASE1, PHASE2","title":"Glutamate Inhibitors in Glioblastoma","status":"RECRUITING","sponsor":"University of Zurich","startDate":"2023-01-01","conditions":"Glioblastoma","enrollment":120},{"nctId":"NCT04698525","phase":"PHASE3","title":"Comparative Study Between Valproate and Memantine in the Prophylactic Management of Episodic Migraine.","status":"COMPLETED","sponsor":"Universidad Autonoma de San Luis Potosí","startDate":"2019-02-15","conditions":"Migraine Headache","enrollment":33},{"nctId":"NCT04834427","phase":"PHASE4","title":"Safety and Efficacy Evaluation of S (+) - Ketamine in Children","status":"ENROLLING_BY_INVITATION","sponsor":"Chinese PLA General Hospital","startDate":"2022-04-20","conditions":"S-ketamine, Esketamine, Acute Pain","enrollment":3000},{"nctId":"NCT03670095","phase":"PHASE1","title":"Study in Healthy Subjects to Compare Two Tablet Formulations of Memantine (Ebixa®) in Fasted and Fed Conditions","status":"COMPLETED","sponsor":"H. Lundbeck A/S","startDate":"2018-08-28","conditions":"Healthy","enrollment":64},{"nctId":"NCT04530006","phase":"NA","title":"Acetyl-Amantadine as a Biomarker in Patients With Glioblastoma","status":"UNKNOWN","sponsor":"CancerCare Manitoba","startDate":"2020-12-02","conditions":"Glioblastoma Multiforme","enrollment":20},{"nctId":"NCT05479032","phase":"PHASE2","title":"Amantadine for Neuroenhancement in Acute Patients Study","status":"UNKNOWN","sponsor":"University Hospital Tuebingen","startDate":"2023-03-01","conditions":"Disorder of Consciousness","enrollment":50},{"nctId":"NCT00401167","phase":"PHASE4","title":"Memantine for Agitation and Aggression in Severe Alzheimer's Disease","status":"COMPLETED","sponsor":"Sunnybrook Health Sciences Centre","startDate":"2006-11","conditions":"Alzheimer's Disease","enrollment":31},{"nctId":"NCT05809414","phase":"PHASE3","title":"Amantadine and Transcranial Magnetic Stimulation for Treating Fatigue in Multiple Sclerosis","status":"UNKNOWN","sponsor":"Hospital San Carlos, Madrid","startDate":"2022-11-28","conditions":"Multiple Sclerosis, Fatigue","enrollment":144},{"nctId":"NCT00755898","phase":"PHASE2","title":"Urinary Excretion of Acetylamantadine by Cancer Patients","status":"COMPLETED","sponsor":"University of Manitoba","startDate":"2003-12","conditions":"Cancer","enrollment":150},{"nctId":"NCT00693121","phase":"PHASE4","title":"Amantadine for Treatment of Symptoms of the Post-traumatic Confusional State","status":"COMPLETED","sponsor":"Methodist Rehabilitation Center","startDate":"2003-04","conditions":"Traumatic Brain Injury, Posttraumatic Confusional State, Delirium","enrollment":79},{"nctId":"NCT04936126","phase":"PHASE4","title":"Comparison of Antidepressant Augmentation With Amantadine vs Pramipexole vs Quetiapine in Treatment Resistant Depression","status":"UNKNOWN","sponsor":"All India Institute of Medical Sciences, Bhubaneswar","startDate":"2021-08-07","conditions":"Treatment Resistant Depression","enrollment":150},{"nctId":"NCT03194906","phase":"PHASE2","title":"Memantine for Prevention of Cognitive Late Effects in Pediatric Patients Receiving Cranial Radiation Therapy for Localized Brain Tumors","status":"COMPLETED","sponsor":"St. Jude Children's Research Hospital","startDate":"2017-11-07","conditions":"Glioma of Brain, Craniopharyngioma, Ependymoma","enrollment":34},{"nctId":"NCT02304302","phase":"PHASE2","title":"Down Syndrome Memantine Follow-up Study","status":"COMPLETED","sponsor":"University Hospitals Cleveland Medical Center","startDate":"2014-10","conditions":"Down Syndrome, Intellectual Disability","enrollment":160},{"nctId":"NCT02580305","phase":"PHASE2","title":"SUVN-502 With Donepezil and Memantine for the Treatment of Moderate Alzheimer's Disease- Phase 2a Study","status":"COMPLETED","sponsor":"Suven Life Sciences Limited","startDate":"2015-09","conditions":"Alzheimer's Disease","enrollment":564},{"nctId":"NCT05834231","phase":"PHASE1, PHASE2","title":"Efficacy of Memantine in Prevention of Oxaliplatin-induced Peripheral Neurotoxicity","status":"UNKNOWN","sponsor":"Mansoura University","startDate":"2023-08","conditions":"Cancer","enrollment":60},{"nctId":"NCT04033419","phase":"PHASE2","title":"Memantine for Prevention of Cognitive Decline in Patients With Breast Cancer","status":"COMPLETED","sponsor":"UNC Lineberger Comprehensive Cancer Center","startDate":"2019-09-25","conditions":"Cognitive Decline, Chemo-brain","enrollment":55},{"nctId":"NCT04527289","phase":"PHASE4","title":"Impact of Amantadine on Traumatic Brain Injury","status":"COMPLETED","sponsor":"Damanhour University","startDate":"2020-09-30","conditions":"Trauma, Brain","enrollment":50},{"nctId":"NCT01071395","phase":"PHASE4","title":"Validation of Dyskinesia Rating Scales","status":"COMPLETED","sponsor":"Rush University Medical Center","startDate":"2010-01","conditions":"Parkinson's Disease","enrollment":68},{"nctId":"NCT05667077","phase":"PHASE2","title":"The Effect of Amantadine on Post-COVD-19 Fatigue","status":"UNKNOWN","sponsor":"Shahid Beheshti University of Medical Sciences","startDate":"2022-12-26","conditions":"Post-COVID-19 Syndrome","enrollment":83},{"nctId":"NCT03860597","phase":"PHASE4","title":"Memantine Effects on Sensorimotor Gating and Neurocognition in Schizophrenia","status":"COMPLETED","sponsor":"University of California, San Diego","startDate":"2018-04-01","conditions":"Schizophrenia, Schizo Affective Disorder, Schizoaffective Disorder","enrollment":42},{"nctId":"NCT00646204","phase":"PHASE4","title":"Namenda (Memantine) for Non-motor Symptoms in Parkinson's Disease","status":"COMPLETED","sponsor":"Baylor College of Medicine","startDate":"2006-04","conditions":"Parkinson's Disease","enrollment":40},{"nctId":"NCT02118727","phase":"PHASE2","title":"Therapy in Amyotrophic Lateral Sclerosis (TAME)","status":"COMPLETED","sponsor":"University of Kansas Medical Center","startDate":"2018-11-07","conditions":"Amyotrophic Lateral Sclerosis, Frontal Temporal Dementia","enrollment":89},{"nctId":"NCT01555697","phase":"PHASE1, PHASE2","title":"Biomarker Strategies for Medication-Enhanced Cognitive Training in Schizophrenia","status":"COMPLETED","sponsor":"University of California, San Diego","startDate":"2014-07","conditions":"Schizophrenia","enrollment":80},{"nctId":"NCT04244058","phase":"EARLY_PHASE1","title":"Changes in Glutamatergic Neurotransmission of Severe TBI Patients","status":"SUSPENDED","sponsor":"Weill Medical College of Cornell University","startDate":"2020-09-23","conditions":"Disorder of Consciousness, Traumatic Brain Injury","enrollment":30},{"nctId":"NCT04952519","phase":"PHASE3","title":"Efficacy of Amantadine Treatment in COVID-19 Patients","status":"TERMINATED","sponsor":"Noblewell","startDate":"2021-03-30","conditions":"Patients With Moderate or Severe COVID-19","enrollment":193},{"nctId":"NCT05538507","phase":"PHASE2","title":"Efficacy of Chinese Traditional Medicine \"Smart Soup\" in Cognition and Behavior Regulation in Alzheimer's Disease","status":"UNKNOWN","sponsor":"Peking Union Medical College Hospital","startDate":"2022-06-01","conditions":"Alzheimer Disease, Mild Cognitive Impairment","enrollment":180},{"nctId":"NCT05531383","phase":"NA","title":"Effect of Early Memantine Administration on Outcome of Patients With Moderate to Severe Traumatic Brain Injury","status":"UNKNOWN","sponsor":"Minia University","startDate":"2021-11-26","conditions":"Traumatic Brain Injury","enrollment":70},{"nctId":"NCT00779324","phase":"NA","title":"Amantadine for the Treatment of Traumatic Brain Injury Irritability and Aggression: A Multi-site Study","status":"COMPLETED","sponsor":"Wake Forest University Health Sciences","startDate":"2009-08","conditions":"Brain Injury, Aggression","enrollment":168},{"nctId":"NCT05430867","phase":"PHASE4","title":"Efficacy and Safety of Memantine and Sodium Oligomannate in Patients With Moderate to Severe Alzheimer's Disease","status":"UNKNOWN","sponsor":"First Affiliated Hospital Xi'an Jiaotong University","startDate":"2022-07-01","conditions":"Treatment, Efficacy, Safety","enrollment":150},{"nctId":"NCT04273737","phase":"PHASE4","title":"Amantadine in Treating Cognitive & Motor Impairments in Adolescents and Adults With Cerebral Palsy","status":"TERMINATED","sponsor":"Columbia University","startDate":"2020-02-28","conditions":"Cerebral Palsy","enrollment":11},{"nctId":"NCT00800514","phase":"NA","title":"Amantadine and Temporal Discrimination in Patients With Traumatic Brain Injury (TBI)","status":"WITHDRAWN","sponsor":"Wake Forest University Health Sciences","startDate":"2009-01","conditions":"Traumatic Brain Injury","enrollment":""},{"nctId":"NCT00627250","phase":"NA","title":"Utility of Amantadine Hydrochloride in the Treatment of Post-traumatic Irritability","status":"COMPLETED","sponsor":"Wake Forest University Health Sciences","startDate":"2003-03","conditions":"Irritable Mood, Aggression, Traumatic Brain Injury","enrollment":76},{"nctId":"NCT00371059","phase":"PHASE4","title":"Memantine for Agitation in Dementia","status":"COMPLETED","sponsor":"East Kent Hospitals University NHS Foundation Trust","startDate":"2007-09","conditions":"DEMENTIA","enrollment":153},{"nctId":"NCT03779672","phase":"PHASE4","title":"Memantine for Epileptic Encephalopathy","status":"COMPLETED","sponsor":"Kenneth Myers, MD","startDate":"2019-02-07","conditions":"Epileptic Encephalopathy, Childhood-Onset","enrollment":30},{"nctId":"NCT02153632","phase":"PHASE3","title":"Efficacy and Safety of Amantadine Hydrogen Chloride (HCl) ER Tablets in Parkinson's Disease Subjects With LID","status":"TERMINATED","sponsor":"Adamas Pharmaceuticals, Inc.","startDate":"2014-07-30","conditions":"Parkinson's Disease, Levodopa Induced Dyskinesia (LID)","enrollment":135},{"nctId":"NCT02153645","phase":"PHASE3","title":"Efficacy and Safety of Amantadine Hydrochloride (HCl) ER Tablets to Treat Parkinson's Disease Patients With LID.","status":"TERMINATED","sponsor":"Adamas Pharmaceuticals, Inc.","startDate":"2014-08-18","conditions":"Parkinson's Disease, Levodopa Induced Dyskinesias (LID)","enrollment":87},{"nctId":"NCT03567057","phase":"PHASE3","title":"A Safety and Efficacy Study of ADS-5102 in Patients With Multiple Sclerosis and Walking Impairment","status":"COMPLETED","sponsor":"Adamas Pharmaceuticals, Inc.","startDate":"2018-07-18","conditions":"Multiple Sclerosis, Walking Impairment","enrollment":424},{"nctId":"NCT03436199","phase":"PHASE3","title":"Safety and Efficacy of ADS-5102 in Multiple Sclerosis Patients With Walking Impairment","status":"COMPLETED","sponsor":"Adamas Pharmaceuticals, Inc.","startDate":"2018-03-29","conditions":"Walking Impairment, Multiple Sclerosis","enrollment":558}],"_emaApprovals":[],"_faersSignals":[{"count":17,"reaction":"GENERAL PHYSICAL HEALTH DETERIORATION"},{"count":13,"reaction":"DEATH"},{"count":13,"reaction":"PYREXIA"},{"count":11,"reaction":"PNEUMONIA"},{"count":10,"reaction":"C-REACTIVE PROTEIN INCREASED"},{"count":9,"reaction":"DELIRIUM"},{"count":9,"reaction":"DYSKINESIA"},{"count":9,"reaction":"FALL"},{"count":7,"reaction":"HALLUCINATION"},{"count":7,"reaction":"TREMOR"}],"_approvalHistory":[],"publicationCount":33,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["PK-merz","amantadine","physiological saline (0.9% NaCl solution)","Osmolex ER Tablet","PKMERZ"],"phase":"marketed","status":"active","brandName":"amantadine sulfate","genericName":"amantadine sulfate","companyName":"Jee-Young Lee","companyId":"jee-young-lee","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Amantadine blocks the M2 ion channel of influenza A virus, preventing viral uncoating and replication, and also increases dopamine release in the central nervous system. Used for Influenza A prophylaxis and treatment, Parkinson's disease, Drug-induced extrapyramidal reactions.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":1,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}